The FDA greenlights treatment-related changes in bone mineral density as a surrogate endpoint in anti-osteoporosis drug trials in postmenopausal women.

Eli Lilly (NYSE:LLY) is rapidly establishing itself as the leader in GLP-1 treatments for weight loss. Its Zepbound injection ...

Nektar Therapeutics is advancing Rezpeg in atopic dermatitis and alopecia areata. Click here for key insights on NKTR's ...

As cybercrime accelerates and security teams face budget cuts and workforce reductions, organizations can no longer rely on ...

Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more ...

Endpoints are no longer limited to PCs and laptops. Today, they encompass servers, mobile devices, Internet of Things (IoT) sensors, operational technology machines, and even intelligent workloads ...

Microsoft's UEM software leverages AI to simplify IT operations, enhance security, and improve the end-user experience across a wide range of devices and platforms. In today’s multi-device, ...

When Faith’s husband dies suddenly, her life and belief system begin to fall apart. Unsure of where to turn, she finds herself drifting into dark places. But when those close to her realize what she’s ...